Your browser doesn't support javascript.
loading
Predicting Survival after Allogeneic Hematopoietic Cell Transplantation in Myelofibrosis: Performance of the Myelofibrosis Transplant Scoring System (MTSS) and Development of a New Prognostic Model.
Hernández-Boluda, Juan-Carlos; Pereira, Arturo; Alvarez-Larran, Alberto; Martín, Ana-Africa; Benzaquen, Ana; Aguirre, Lourdes; Mora, Elvira; González, Pedro; Mora, Jorge; Dorado, Nieves; Sampol, Antonia; García-Gutiérrez, Valentín; López-Godino, Oriana; Fox, María-Laura; Reguera, Juan Luis; Pérez-Encinas, Manuel; Pascual, María-Jesús; Xicoy, Blanca; Parody, Rocío; González-Pinedo, Leslie; Español, Ignacio; Avendaño, Alejandro; Correa, Juan-Gonzalo; Vallejo, Carlos; Jurado, Manuel; García-Cadenas, Irene; Osorio, Santiago; Durán, María-Antonia; Sánchez-Guijo, Fermín; Cervantes, Francisco; Piñana, José-Luis.
Afiliação
  • Hernández-Boluda JC; Hematology Department, Hospital Clínico Universitario, INCLIVA, University of Valencia, Valencia, Spain. Electronic address: hernandez_jca@gva.es.
  • Pereira A; Hemotherapy and Hemostasis Department, Hospital Clinic, Barcelona, Spain.
  • Alvarez-Larran A; Hematopoietic Stem Cell Transplantation Unit, Hospital Clinic, IDIBAPS, University of Barcelona, Barcelona Institut Josep Carreras, Barcelona, Spain.
  • Martín AA; Hematology Department, Hospital Universitario de Salamanca, IBSAL, Salamanca, Spain.
  • Benzaquen A; Hematology Department, Hospital Clínico Universitario, INCLIVA, University of Valencia, Valencia, Spain.
  • Aguirre L; Hematology Department, Hospital Universitario de Donostia, San Sebastián, Spain.
  • Mora E; Hematology Department, Hospital La Fe, IIS La Fe, Valencia, Spain.
  • González P; Hematology Department, Hospital Universitario Virgen de las Nieves, Granada, Spain.
  • Mora J; Hematology Department, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute (IIB Sant-Pau) and José Carreras Leukemia Research Institute, Autonomous University of Barcelona (UAB), Barcelona, Spain.
  • Dorado N; Hematology Department, Hospital Gregorio Marañón, Gregorio Marañón Health Research Institute (IiSGM), Madrid, Spain.
  • Sampol A; Hematology Department, Hospital Son Espases, Mallorca, Spain.
  • García-Gutiérrez V; Hematology Department, Hospital Ramón y Cajal, Madrid, Spain.
  • López-Godino O; Hematology and Medical Oncology Department, Hospital Universitario Morales Meseguer, Centro Regional de Hemodonación, Instituto Murciano de Investigación Biomédica-Arrixaca, Murcia, Spain.
  • Fox ML; Hematology Department, Hospital Universitari Vall d'Hebron, Vall d'Hebron Institute of Oncology (VHIO), Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Reguera JL; Hematology Department, Hospital Virgen del Rocío, Sevilla, Spain.
  • Pérez-Encinas M; Hematology Department, Hospital Clínico Universitario, Santiago de Compostela, Spain.
  • Pascual MJ; Hematology Department, Hospital Regional, Málaga, Spain.
  • Xicoy B; Hematology Department, Institut Català d'Oncologia-Hospital Germans Trias i Pujol, Josep Carreras Leukemia Research Institute, Autonomous University of Barcelona, Badalona, Spain.
  • Parody R; Hematology Department, Institut Català d'Oncologia, Hospital Duran i Reynals, Hospitalet de Llobregat, Barcelona, Spain.
  • González-Pinedo L; Hematology Department, Hospital Dr Negrín, Las Palmas de Gran Canaria, Spain.
  • Español I; Hematology Department, Hospital Virgen de la Arrixaca, Murcia, Spain.
  • Avendaño A; Hematology Department, Hospital Universitario de Salamanca, IBSAL, Salamanca, Spain.
  • Correa JG; Hematopoietic Stem Cell Transplantation Unit, Hospital Clinic, IDIBAPS, University of Barcelona, Barcelona Institut Josep Carreras, Barcelona, Spain.
  • Vallejo C; Hematology Department, Hospital Universitario de Donostia, San Sebastián, Spain.
  • Jurado M; Hematology Department, Hospital Universitario Virgen de las Nieves, Granada, Spain.
  • García-Cadenas I; Hematology Department, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute (IIB Sant-Pau) and José Carreras Leukemia Research Institute, Autonomous University of Barcelona (UAB), Barcelona, Spain.
  • Osorio S; Hematology Department, Hospital Gregorio Marañón, Gregorio Marañón Health Research Institute (IiSGM), Madrid, Spain.
  • Durán MA; Hematology Department, Hospital Son Espases, Mallorca, Spain.
  • Sánchez-Guijo F; Hematology Department, Hospital Universitario de Salamanca, IBSAL, Salamanca, Spain.
  • Cervantes F; Hematopoietic Stem Cell Transplantation Unit, Hospital Clinic, IDIBAPS, University of Barcelona, Barcelona Institut Josep Carreras, Barcelona, Spain.
  • Piñana JL; Hematology Department, Hospital La Fe, IIS La Fe, Valencia, Spain.
Biol Blood Marrow Transplant ; 26(12): 2237-2244, 2020 12.
Article em En | MEDLINE | ID: mdl-32717433
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Mielofibrose Primária Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Biol Blood Marrow Transplant Assunto da revista: HEMATOLOGIA / TRANSPLANTE Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Mielofibrose Primária Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Biol Blood Marrow Transplant Assunto da revista: HEMATOLOGIA / TRANSPLANTE Ano de publicação: 2020 Tipo de documento: Article